Markets.News

CRNX  CRINETICS PHARMACEUTICALS INC

+ add to watchlist

$50.49

neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.

Mkt Cap: $4.75B

52 Week High: $56.53

P/E: -16.43

52 Week Low: $24.10

Dividend: $0.00

Shares Outstanding: 94.18M

This news is delayed by 15 minutes, sign up now to get live news & full features.